Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2011

Open Access 01-12-2011 | Case report

Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: a case report

Authors: Yutaka Nakamura, Yu Utsumi, Naomi Suzuki, Yoshio Nakajima, Okinori Murata, Nobuhito Sasaki, Hiroo Nitanai, Hiromi Nagashima, Shinya Miyamoto, Jun Yaegashi, Tomoki Hatakeyama, Yoshihiro Shibano, Kyoko Yarita, Katsuhiko Kamei, Toshihide Nakadate, Shigeatsu Endo, Yasuo Terayama, Kohei Yamauchi

Published in: Journal of Medical Case Reports | Issue 1/2011

Login to get access

Abstract

Introduction

Scedosporium apiospermum is increasingly recognized as a cause of localized and disseminated mycotic infections in near-drowning victims.

Case presentation

We report the case of a 59-year-old Japanese woman who was a survivor of a tsunami in northeastern Japan and who had lung and brain abscesses caused by S. apiospermum. Initially, an aspergillus infection was suspected, so she was treated with micafungin. However, computed tomography scans of her chest revealed lung abscesses, and magnetic resonance images demonstrated multiple abscesses in her brain. S. apiospermum was cultured from her bronchoalveolar lavage fluid, and antimycotic therapy with voriconazole was initiated. Since she developed an increase in the frequency of premature ventricular contractions, an adverse drug reaction to the voriconazole was suspected. She was started on a treatment of a combination of low-dose voriconazole and liposomal amphotericin B. After combination therapy, further computed tomography scans of the chest and magnetic resonance images of her brain showed a demarcation of abscesses.

Conclusions

Voriconazole appeared to have a successful record in treating scedosporiosis after a near drowning but, owing to several adverse effects, may possibly not be recommended. Thus, a combination treatment of low-dose voriconazole and liposomal amphotericin B may be a safe and effective treatment for an S. apiospermum infection. Even though a diagnosis of scedosporiosis may be difficult, a fast and correct etiological diagnosis could improve the patient's chance of recovery in any case.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fisher JF, Shadomy S, Teabeaut JR, Woodward J, Michaels GE, Newman MA, White E, Cook P, Seagraves A, Yaghmai F, Rissing JP: Near-drowning complicated by brain abscess due to Petriellidium boydii. Arch Neurol. 1982, 39: 511-513.CrossRefPubMed Fisher JF, Shadomy S, Teabeaut JR, Woodward J, Michaels GE, Newman MA, White E, Cook P, Seagraves A, Yaghmai F, Rissing JP: Near-drowning complicated by brain abscess due to Petriellidium boydii. Arch Neurol. 1982, 39: 511-513.CrossRefPubMed
2.
go back to reference Hachimi-Idrissi S, Willemsen M, Desprechins B, Naessens A, Goossens A, De Meirleir L, Ramet J: Pseudallescheria boydii and brain abscesses. Pediatr Infect Dis J. 1990, 9: 737-741. 10.1097/00006454-199010000-00011.CrossRefPubMed Hachimi-Idrissi S, Willemsen M, Desprechins B, Naessens A, Goossens A, De Meirleir L, Ramet J: Pseudallescheria boydii and brain abscesses. Pediatr Infect Dis J. 1990, 9: 737-741. 10.1097/00006454-199010000-00011.CrossRefPubMed
3.
go back to reference Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E: Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 2003, 36: 1122-1131. 10.1086/374557.CrossRefPubMed Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E: Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 2003, 36: 1122-1131. 10.1086/374557.CrossRefPubMed
4.
go back to reference Schwartz S, Reisman A, Troke PF: The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection. 2011, 39: 201-210. 10.1007/s15010-011-0108-6.CrossRefPubMed Schwartz S, Reisman A, Troke PF: The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection. 2011, 39: 201-210. 10.1007/s15010-011-0108-6.CrossRefPubMed
5.
go back to reference Espinel-Ingroff A, Johnson E, Hockey H, Troke P: Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole phase III clinical studies. J Antimicrob Chemother. 2008, 61: 616-620. 10.1093/jac/dkm518.CrossRefPubMed Espinel-Ingroff A, Johnson E, Hockey H, Troke P: Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole phase III clinical studies. J Antimicrob Chemother. 2008, 61: 616-620. 10.1093/jac/dkm518.CrossRefPubMed
6.
go back to reference Elter T, Sieniawski M, Gossmann A, Wickenhauser C, Schröder U, Seifert H, Kuchta J, Burhenne J, Riedel KD, Fätkenheuer G, Cornely OA: Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman. Int J Antimicrob Agents. 2006, 28: 262-265. 10.1016/j.ijantimicag.2006.04.006.CrossRefPubMed Elter T, Sieniawski M, Gossmann A, Wickenhauser C, Schröder U, Seifert H, Kuchta J, Burhenne J, Riedel KD, Fätkenheuer G, Cornely OA: Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman. Int J Antimicrob Agents. 2006, 28: 262-265. 10.1016/j.ijantimicag.2006.04.006.CrossRefPubMed
7.
go back to reference Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A: Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. J Clin Pharmacol. 2002, 42: 395-402. 10.1177/0091270002424005.CrossRefPubMed Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A: Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. J Clin Pharmacol. 2002, 42: 395-402. 10.1177/0091270002424005.CrossRefPubMed
8.
go back to reference Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N: Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities. J Clin Pharmacol. 2006, 46: 235-243. 10.1177/0091270005283837.CrossRefPubMed Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N: Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities. J Clin Pharmacol. 2006, 46: 235-243. 10.1177/0091270005283837.CrossRefPubMed
9.
go back to reference Eiden C, Peyrière H, Tichit R, Cociglio M, Amedro P, Blayac JP, Margueritte G, Hillaire-Buys D: Inherited long QT syndrome revealed by antifungals drug-drug interaction. J Clin Pharm Ther. 2007, 32: 321-324. 10.1111/j.1365-2710.2007.00812.x.CrossRefPubMed Eiden C, Peyrière H, Tichit R, Cociglio M, Amedro P, Blayac JP, Margueritte G, Hillaire-Buys D: Inherited long QT syndrome revealed by antifungals drug-drug interaction. J Clin Pharm Ther. 2007, 32: 321-324. 10.1111/j.1365-2710.2007.00812.x.CrossRefPubMed
10.
go back to reference Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE, EUROFUNG Network: In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother. 2002, 46: 62-68. 10.1128/AAC.46.1.62-68.2002.CrossRefPubMedPubMedCentral Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE, EUROFUNG Network: In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother. 2002, 46: 62-68. 10.1128/AAC.46.1.62-68.2002.CrossRefPubMedPubMedCentral
11.
go back to reference Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL: Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006, 50: 917-921. 10.1128/AAC.50.3.917-921.2006.CrossRefPubMedPubMedCentral Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL: Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006, 50: 917-921. 10.1128/AAC.50.3.917-921.2006.CrossRefPubMedPubMedCentral
12.
go back to reference Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E: Scedosporium apiospermum infection after near-drowning. Mycoses. 2007, 50: 412-421. 10.1111/j.1439-0507.2007.01388.x.CrossRefPubMed Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E: Scedosporium apiospermum infection after near-drowning. Mycoses. 2007, 50: 412-421. 10.1111/j.1439-0507.2007.01388.x.CrossRefPubMed
13.
go back to reference Troke P, Aguirrebengoa K, Arteaga C, Ellis D, Heath CH, Lutsar I, Rovira M, Nguyen Q, Slavin M, Chen SC, Global Scedosporium Study Group: Treatment of Scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother. 2008, 52: 1743-1750. 10.1128/AAC.01811-10.CrossRefPubMedPubMedCentral Troke P, Aguirrebengoa K, Arteaga C, Ellis D, Heath CH, Lutsar I, Rovira M, Nguyen Q, Slavin M, Chen SC, Global Scedosporium Study Group: Treatment of Scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother. 2008, 52: 1743-1750. 10.1128/AAC.01811-10.CrossRefPubMedPubMedCentral
14.
go back to reference Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA: Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents Chemother. 1995, 39: 1361-1364.CrossRefPubMedPubMedCentral Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA: Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents Chemother. 1995, 39: 1361-1364.CrossRefPubMedPubMedCentral
15.
go back to reference Rodríguez MM, Calvo E, Serena C, Mariné M, Pastor FJ, Guarro J: Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother. 2009, 53: 2153-2155. 10.1128/AAC.01477-08.CrossRefPubMedPubMedCentral Rodríguez MM, Calvo E, Serena C, Mariné M, Pastor FJ, Guarro J: Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother. 2009, 53: 2153-2155. 10.1128/AAC.01477-08.CrossRefPubMedPubMedCentral
Metadata
Title
Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: a case report
Authors
Yutaka Nakamura
Yu Utsumi
Naomi Suzuki
Yoshio Nakajima
Okinori Murata
Nobuhito Sasaki
Hiroo Nitanai
Hiromi Nagashima
Shinya Miyamoto
Jun Yaegashi
Tomoki Hatakeyama
Yoshihiro Shibano
Kyoko Yarita
Katsuhiko Kamei
Toshihide Nakadate
Shigeatsu Endo
Yasuo Terayama
Kohei Yamauchi
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2011
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-5-526

Other articles of this Issue 1/2011

Journal of Medical Case Reports 1/2011 Go to the issue